Revvity Inc. (NYSE:RVTY) Receives Average Rating of "Moderate Buy" from Brokerages

Key Points

• Revvity Inc. has received a consensus rating of "Moderate Buy" from fourteen analysts, with ten analysts recommending buying the stock and four advising to hold it.
• The average twelve-month price target for Revvity is $120.07, though some analysts have adjusted their targets down recently, with Stifel Nicolaus setting it at $110.00.
• Revvity has declared a quarterly dividend of $0.07 per share, which is expected to be paid on November 7, indicating a relatively low payout ratio of 11.86%.

Shares of Revvity Inc. (NYSE:RVTY - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fourteen analysts that are covering the company, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $120.0714.

Several research analysts recently weighed in on RVTY shares. Stifel Nicolaus dropped their target price on Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research note on Tuesday, July 29th. Evercore ISI dropped their target price on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. UBS Group upgraded Revvity from a "neutral" rating to a "buy" rating and dropped their price target for the company from $145.00 to $115.00 in a research note on Thursday, May 1st. Bank of America dropped their price target on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Finally, Wall Street Zen downgraded Revvity from a "buy" rating to a "hold" rating in a research note on Sunday, August 3rd.

Institutional Trading of Revvity

Several large investors have recently added to or reduced their stakes in RVTY. Price T Rowe Associates Inc. MD grew its stake in Revvity by 25.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company's stock valued at $1,011,863,000 after purchasing an additional 1,932,314 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Revvity by 8.5% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company's stock valued at $2,382,163,000 after purchasing an additional 1,754,403 shares during the last quarter. EdgePoint Investment Group Inc. grew its stake in Revvity by 26.7% during the 2nd quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company's stock valued at $656,696,000 after purchasing an additional 1,428,813 shares during the last quarter. Norges Bank purchased a new stake in shares of Revvity in the second quarter worth about $124,574,000. Finally, Invesco Ltd. boosted its stake in shares of Revvity by 25.8% in the second quarter. Invesco Ltd. now owns 2,207,202 shares of the company's stock worth $213,481,000 after buying an additional 452,343 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Trading Down 3.0%

Shares of NYSE RVTY opened at $88.46 on Thursday. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. The business has a fifty day simple moving average of $94.31 and a two-hundred day simple moving average of $98.44. The firm has a market cap of $10.27 billion, a PE ratio of 37.48, a price-to-earnings-growth ratio of 2.45 and a beta of 0.91. Revvity has a twelve month low of $85.12 and a twelve month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The firm had revenue of $720.28 million during the quarter, compared to analyst estimates of $711.26 million. During the same period in the previous year, the company posted $1.22 EPS. The business's revenue for the quarter was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Analysts expect that Revvity will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity's payout ratio is presently 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.